INSP Financials

Income Statement
MetricQ2 2026Q1 2026Q4 2025Q3 2025Q2 2025
Revenue
200.6M
-2.0%
204.6M
-24.0%
269.1M
+19.9%
224.5M
+3.4%
217.1M
Cost of Revenue
29.1M
+5.2%
27.7M
-23.3%
36.1M
+13.5%
31.8M
-8.4%
34.7M
Gross Profit
171.5M
-3.1%
176.9M
-24.1%
233.0M
+20.9%
192.7M
+5.7%
182.4M
Operating Expenses
172.0M
-3.4%
178.0M
-4.7%
186.9M
+2.1%
183.1M
-1.4%
185.7M
R&D
24.7M
-4.4%
25.8M
+3.5%
24.9M
+3.0%
24.2M
-7.6%
26.2M
SG&A
147.3M
-3.2%
152.2M
-6.0%
162.0M
+1.9%
158.9M
-0.4%
159.5M
Operating Income
-514000
+54.0%
-1118000
-102.4%
46.1M
+378.1%
9.6M
+390.8%
-3316000
EBITDA
4.1M
+2.3%
4.0M
-92.0%
49.9M
+274.8%
13.3M
+13492.9%
98.0K
Net Income
314.0K
+102.8%
-11294000
-108.3%
136.1M
+1270.2%
9.9M
+376.5%
-3592000
EPS (Basic)
$0.01
+102.6%
$-0.39
-108.3%
$4.70
+1282.4%
$0.34
+383.3%
$-0.12
EPS (Diluted)
$0.01
+102.6%
$-0.39
-108.5%
$4.60
+1252.9%
$0.34
+383.3%
$-0.12
Shares (Diluted)
28.9M
+0.8%
28.7M
-3.1%
29.6M
+0.0%
29.6M
+0.3%
29.5M
Inspire Medical Systems (INSP) โ€” Financials